CKD-EPI与EKFC肾小球滤过率估算方程选择
该研究在4050名成人独立人群中评估CKD-EPI与EKFC的eGFRcr、eGFRcys及eGFRcr-cys方程的偏差与P30。结果示eGFRcr-cys方程整体表现优于eGFRcr或eGFRcys,且亚组差异更小;eGFRcr方程间差异较大反映地区人群肌酐非GFR决定因素差异,单用eGFRcr方程无法同时最大化准确性与统一性。
要点
- eGFRcr-cys方程整体表现优于eGFRcr或eGFRcys,且种族、性别和年龄亚组间差异更小。
- CKD-EPI与EKFC方程系数相似,二者正趋于收敛。
- 选择eGFRcr方程时需在准确性与全球统一性之间权衡,广泛使用胱抑素C可避免此权衡。
核心结论
- CKD-EPI和EKFC方程正趋于收敛。
- 选择当前可用的eGFRcr方程用于跨区域实施时,无法同时最大化准确性和统一性。
- 决策除性能外还应考虑方程开发方法。
- 更广泛地联合使用胱抑素C与肌酐可同时最大化当前可用方程的GFR估算准确性和统一性。
研究设计与样本
- 在由12项研究汇总的4050名成人独立研究人群中评估方程的偏差和P30及方程开发方法。
- 平均(SD)实测GFR为76.4(29.6)ml/min per 1.73 m²,年龄57.0(17.4)岁,女性1557名(38%),Black参与者579名(14%)。
主要发现
- CKD-EPI和EKFC方程中肌酐、胱抑素C、年龄和性别的系数相似。
- eGFRcr-cys方程在总体人群中表现(偏差<±5 ml/min per 1.73 m²且P30>90%)优于eGFRcr或eGFRcys方程,且种族、性别和年龄亚组间差异更少。
- 亚组间性能差异反映源人群多样性及方程开发中race和sex变量使用的差异。
- eGFRcr方程间较大差异反映肌酐非GFR决定因素的地区人群差异。
关键数值与推荐
- eGFRcr-cys方程在总体人群中偏差<±5 ml/min per 1.73 m²且P30>90%。
临床怎么用
- 决策选择eGFR方程时应考虑方程开发方法而不仅是性能。
- 更广泛地联合使用胱抑素C与肌酐可同时最大化当前可用方程的GFR估算准确性和统一性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: New eGFR equations from Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and European Kidney Function Consortium (EKFC) using creatinine (eGFRcr), cystatin C (eGFRcys), and both (eGFRcr-cys) have sufficient accuracy for use in clinical practice, leading to uncertainty in selecting equations for implementation. The authors evaluated performance of equations in an independent population of 4050 adults and evaluated other considerations important for implementation. They found that CKD-EPI and EKFC equations are approaching convergence, with better performance of eGFRcr-cys equations in the overall group and fewer differences among race, sex, and age subgroups than eGFRcr equations. Larger differences among eGFRcr equations reflect regional population differences in creatinine, forcing a trade-off between accuracy and uniformity in global implementation of eGFRcr equations. More widespread use of cystatin C could avoid this trade-off. BACKGROUND: New CKD-EPI and EKFC eGFR equations using eGFRcr, eGFRcys, and both (eGFRcr-cys) have sufficient accuracy for use in clinical practice. A better understanding of the equations, including their performance in race, sex and age subgroups, is important for selection of eGFR equations for global implementation. METHODS: We evaluated performance (bias and P 30 ) of equations and methods used for equation development in an independent study population comprising 4050 adults pooled from 12 studies. The mean (SD) measured GFR was 76.4 (29.6) ml/min per 1.73 m 2 and age 57.0 (17.4) years, with 1557 (38%) women and 579 (14%) Black participants. RESULTS: Coefficients for creatinine, cystatin C, age, and sex in the CKD-EPI and EKFC equations are similar. Performance of the eGFRcr-cys equations in the overall population (bias <±5 ml/min per 1.73 m 2 and P 30 >90%) was better than the eGFRcr or eGFRcys equations, with fewer differences among race, sex, and age subgroups. Differences in performance across subgroups reflected differences in diversity of source populations and use of variables for race and sex for equation development. Larger differences among eGFRcr equations reflected regional population differences in non-GFR determinants of creatinine. CONCLUSION: CKD-EPI and EKFC equations are approaching convergence. It is not possible to maximize both accuracy and uniformity in selecting one of the currently available eGFRcr equations for implementation across regions. Decisions should consider methods for equation development in addition to performance. Wider use of cystatin C with creatinine could maximize both accuracy and uniformity of GFR estimation using currently available equations.
引用
- Inker LA, Tighiouart H, Adingwupu OM, et al. CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults. J Am Soc Nephrol. 2023. PMID: 37796982. doi:10.1681/ASN.0000000000000227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。